Demographics of North American respondents with FA
| . | Total . | Solid tumors . | Leukemia . | MDS* . | No cancer . |
|---|---|---|---|---|---|
| No. of cases | 145 | 14† | 9 | 23 | 122 |
| Male to female ratio‡ | 76:69 | 6:8 | 6:3 | 17:6 | 64:58 |
| 6:6‡ | |||||
| Median age, y (range) | |||||
| at FA diagnosis | 4.8 (0-45) | 7.6 (0.09-45) | 3.8 (0-11) | 5.3 (0-41) | 4.6 (0-41) |
| at outcome | NA | 28.9 (7-45) | 11.3 (3-24) | 12.3 (2-41) | NA |
| . | Total . | Solid tumors . | Leukemia . | MDS* . | No cancer . |
|---|---|---|---|---|---|
| No. of cases | 145 | 14† | 9 | 23 | 122 |
| Male to female ratio‡ | 76:69 | 6:8 | 6:3 | 17:6 | 64:58 |
| 6:6‡ | |||||
| Median age, y (range) | |||||
| at FA diagnosis | 4.8 (0-45) | 7.6 (0.09-45) | 3.8 (0-11) | 5.3 (0-41) | 4.6 (0-41) |
| at outcome | NA | 28.9 (7-45) | 11.3 (3-24) | 12.3 (2-41) | NA |
NA indicates data not applicable.
MDS was not considered to be a cancer. This column includes 4 subjects who had MDS prior to leukemia, and 1 who had MDS prior to a solid tumor. Persons with MDS are included in the solid tumors, leukemia, and no cancer columns.
Fourteen individuals had 18 tumors: 6 head and neck cancers, 2 each of esophageal, liver, and cervix cancers, 3 vulvar cancers, and 1 each of osteosarcoma, soft-tissue sarcoma, and brain cancer. None of the respondents reported having developed either breast or ovary cancer.
Male-to-female ratio after exclusion of 2 women with only gynecologic cancers.